OSE Pharma SA (OSE) — Long-term Investment Intensity
OSE Pharma SA (OSE) has a Long-term Investment Intensity of 0.1% as of June 2019. Long-term investments of €141.00K represent 0.1% of total assets of €94.91 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See OSE net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
OSE Pharma SA Long-term Investment Intensity (2013–2018)
This chart shows how OSE Pharma SA's Long-term Investment Intensity has evolved across 3 annual periods from 2013 to 2018. As of June 2019, the intensity stands at 0.1%, reflecting long-term investments of €141.00K against total assets of €94.91 Million EUR. Also explore OSE Pharma SA assets under control for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for OSE Pharma SA (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for OSE Pharma SA from 2013 to 2018, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of OSE Pharma SA.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.1% | €103.00K | €76.90 Million | ▲ +0.0 pp |
| 2017 | 0.1% | €77.00K | €77.35 Million | ▼ -8.2 pp |
| 2013 | 8.3% | €28.00K | €336.00K | — |